On Tuesday, Twist Bioscience Corp (NASDAQ: TWST) was 3.05% up from the session before settling in for the closing price of $34.77. A 52-week range for TWST has been $27.12 – $60.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 1.70% over the past five years. When this article was written, the company’s average yearly earnings per share was at 40.52%. With a float of $56.80 million, this company’s outstanding shares have now reached $59.86 million.
Let’s look at the performance matrix of the company that is accounted for 923 employees. In terms of profitability, gross margin is 46.7%, operating margin of -57.86%, and the pretax margin is -55.03%.
Twist Bioscience Corp (TWST) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Twist Bioscience Corp stocks. The insider ownership of Twist Bioscience Corp is 5.21%, while institutional ownership is 110.06%. The most recent insider transaction that took place on Jul 09 ’25, was worth 93,420. In this transaction Chief Financial Officer of this company sold 2,449 shares at a rate of $38.15, taking the stock ownership to the 103,569 shares. Before that another transaction happened on Jul 09 ’25, when Company’s Officer proposed sale 2,449 for $38.15, making the entire transaction worth $93,419.
Twist Bioscience Corp (TWST) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 36.77% during the next five years compared to 1.70% growth over the previous five years of trading.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
You can see what Twist Bioscience Corp (TWST) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.26, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -1.35 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Twist Bioscience Corp (NASDAQ: TWST) saw its 5-day average volume 0.74 million, a negative change from its year-to-date volume of 1.08 million. As of the previous 9 days, the stock’s Stochastic %D was 15.88%.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 48.04%, which indicates a significant increase from 32.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.70 in the past 14 days, which was lower than the 2.42 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.67, while its 200-day Moving Average is $41.23. Nevertheless, the first resistance level for the watch stands at $36.27 in the near term. At $36.71, the stock is likely to face the second major resistance level. The third major resistance level sits at $37.30. If the price goes on to break the first support level at $35.24, it is likely to go to the next support level at $34.65. The third support level lies at $34.21 if the price breaches the second support level.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
There are 59,916K outstanding shares of the company, which has a market capitalization of 2.15 billion. As of now, sales total 312,970 K while income totals -208,730 K. Its latest quarter income was 92,790 K while its last quarter net income were -39,330 K.
